0001209191-21-064933.txt : 20211116
0001209191-21-064933.hdr.sgml : 20211116
20211116210346
ACCESSION NUMBER: 0001209191-21-064933
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211114
FILED AS OF DATE: 20211116
DATE AS OF CHANGE: 20211116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McKenna Mark C.
CENTRAL INDEX KEY: 0001749623
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40187
FILM NUMBER: 211418175
MAIL ADDRESS:
STREET 1: 400 SOMERSET CORPORATE BOULEVARD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prometheus Biosciences, Inc.
CENTRAL INDEX KEY: 0001718852
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 814282653
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9410 CARROLL PARK DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 200-7888
MAIL ADDRESS:
STREET 1: 9410 CARROLL PARK DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Precision IBD, Inc.
DATE OF NAME CHANGE: 20171004
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-14
0
0001718852
Prometheus Biosciences, Inc.
RXDX
0001749623
McKenna Mark C.
C/O PROMETHEUS BIOSCIENCES, INC.
9410 CARROLL PARK DRIVE
SAN DIEGO
CA
92121
1
1
0
0
Chairman, President & CEO
Stock Option (Right to Buy)
36.32
2021-11-14
4
A
0
290000
0.00
A
2031-11-13
Common Stock
290000
290000
D
25% of the shares subject to the option will vest on November 14, 2022, and 1/48th of the shares subject to the option will vest monthly thereafter, subject to the Reporting Person's continued service with the Issuer through each vest date.
/s/ Timothy K. Andrews, attorney-in-fact for Mark C. McKenna
2021-11-16